Related Experiment Video
Updated: Oct 8, 2025
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Hemodynamic considerations in preterm infants born at less than 25 weeks gestation
Bryan P Finn1, Neidin Bussmann1, Tom Beechinor1
1Department of Neonatology, Cork University Maternity Hospital, Wilton, Cork, Ireland; Department of Paediatrics and Child Health, University College Cork, Wilton, Cork, Ireland.
Insights
Diagnosing cardiovascular issues in extremely preterm infants is challenging due to limited data. This study offers a practical approach to understanding their unique physiology and guiding treatment for better outcomes.
Area of Science:
- Neonatal Physiology
- Pediatric Cardiology
- Perinatal Medicine
Background:
- Improving survival rates in infants born before 25 weeks gestation presents diagnostic challenges.
- Limited normative cardiovascular data for extremely preterm infants necessitates a pragmatic approach.
- Over-reliance on data from older infants can lead to inaccurate assessments.
Purpose of the Study:
- To provide a pragmatic cardiovascular approach for diagnosing and managing extremely preterm infants.
- To highlight the unique physiological characteristics of this population.
- To guide clinical decision-making in the absence of extensive normative data.
Main Methods:
- Review of unique cardiovascular physiology in preterm infants (immature myocardium, vascular tone, patent ductus arteriosus).
- Emphasis on thorough clinical history and case-specific contributing factors.
- Discussion of balancing bedside assessment with objective perfusion markers.
Main Results:
- Understanding unique preterm cardiovascular physiology is essential for accurate diagnosis.
- Clinical history is crucial for identifying contributing factors.
- Objective markers of perfusion are vital but challenging to obtain with minimal handling.
Conclusions:
- A pragmatic, physiology-based approach is necessary for diagnosing cardiovascular conditions in extremely preterm infants.
- Treatment decisions for inotropes and patent ductus arteriosus require careful consideration due to limited evidence.
- Further research is needed to establish normative cardiovascular data for this vulnerable population.
Abstract:
As survival rates continue to improve for infants born at less than 25 weeks gestation, delineating normal cardiovascular physiology from pathophysiology becomes much more challenging. With a paucity of 'normative' data for such infants, an over-reliance on studies at older gestations can result in a 'best guess' approach. Here we offer a pragmatic approach to these diagnostic challenges from a cardiovascular viewpoint. An appreciation of the unique physiology, from the immature myocardium and altered vascular tone to an innately large patent ductus arteriosus is essential, as is a thorough history for case specific contributing factors. We explore the additional difficulties in achieving a balance between minimal handling at the bedside and delineating important objective markers of perfusion. Finally, we discuss treatment approaches including inotrope therapy and patent ductus treatment, acknowledging the limited data available to guide these decisions.
